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ravel medicine and the inﬂuenza pandemic
Invited Presentation)
7.001
rom the Americas to the World
. Sotelo Morales
National Autonomous University of Mexico, Mexico City,
exico
In April, 2009 a new inﬂuenza virus, from porcine ori-
in, was detected in Mexico City and blamed as responsible
or the death of young adults with pneumonia. The patients
ere seen within the brief lapse of a week at the National
nstitute of Respiratory Diseases of Mexico; three main fac-
ors contributed to trigger the awakening call from the
exican Health authority that evolved, within a few weeks,
nto an unprecedented international epidemiological alert
rchestrated by the World Health Organization which cul-
inated with the ‘‘Pandemic alert grade VI’’; it meant that
he disease had already disseminated worldwide; the factors
ere: a) the presence of various cases of severe inﬂuenza
n healthy adults, b) the presence of the disease in the
iddle of spring, an abnormal timing for seasonal inﬂuenza
nd c) the identiﬁcation by molecular methods of a brand
ew inﬂuenza virus from porcine origin infecting humans.
ccording to the standards settled by the WHO these char-
cteristics represented the much feared possibility of an
nﬂuenza pandemic of potential catastrophic consequences;
hus, the Ministry of Health of Mexico implemented at mea-
ures which had already been planned two years before
n the case of facing such event. The Minister of Health
ppeared on national TV indicating the closure of schools
t all levels in Mexico City and various other actions aiming
o social distancing and medical alert in all health institu-
ions, together with the development of technical skills for
he reliable detection of the new virus in specialized labora-
ories. Through the epidemic in Mexico several new factors
ere learned, the capacity of society to deal with similar
vents was put to test. From this experience, several scien-
iﬁc reports from our Institutes have been published; they
rovide a new framework for more efﬁcient responses in
uture events.
oi:10.1016/j.ijid.2010.02.1494
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linical Spectrum of Disease. Inﬂuenza AH1N1 2009
. Dabanch Pena
Hospital Militar de Santiago, Santiago, Chile
In Chile, the ﬁrst case of 2009 pandemic inﬂuenza A
1N1 virus infection was detected on May 17. Since then all
nﬂuenza like illness cases were notiﬁed to Chilean Health
ecretary. A total of 367.041 cases were reported, 1585
equired hospitalization (0.56%) and 130 died.
The surveillance in Chile shows that the majority of those
nfected had a mild disease.
The most affected age group was between 5 and 14.
ebrile respiratory infection was the most common clinical
anifestation and range from self limited to severe illness.
t
h
r
bternational Congress on Infectious Diseases (ICID) Abstracts
n the outpatient group, 97% had fever, 97% headache, 93.5%
yalgias, 90% cough, 88.3% sore throat, 84% rhinorrhea,
3.8% join pain, 36% nausea, 29.4% diarrhea. Time between
nset symptoms and second case was 3.6 days (range 1 — 9).
Of the 1585 admitted to hospital, 52% were females,
edian age 33 years (range11 to 94), 56% had underlying
edical condition, average time from the onset of illness
o hospital admission was 3.6 days. Symptoms at presenta-
ion included fever 83%, cough 92.7%, dyspnea 83%, myalgias
3%, hypoxia 50.8%, cyanosis 27.4%, hypotension 18.6%, and
.3% seizures.
Pneumonia was the diagnosis in 77% patients.
130 patients died, all has been admitted to and ICU. The
edian age was 44 years (range 4 months to 89 years), 87.5%
ad underlying medical condition. The cause of death was
evere respiratory failure in 34%, septic shock in 19%, bilat-
ral pneumonia 17% and multi organic failure in 16%. Almost
ll patients received antiviral treatment.
Surveillance in Chile of the 2009 inﬂuenza A H1N1 cases
llow to characterize the clinical spectrum of the disease in
his ﬁrst pandemic wave.
oi:10.1016/j.ijid.2010.02.1495
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nterim lessons from 2009
. Alves
Institute for Infectious Diseases Emilio Ribas, Sao Paulo,
razil
Through the epidemiological week 37/2009, WHO
eported more than 300,000 conﬁrmed cases and almost
,000 deaths produced by pandemic inﬂuenza H1N1 in 191
fﬁliated countries.
During the peak of transmission in 2009, the Southern
one countries, Chile, Argentina and Southern regions of
razil, reported the highest number of cases. According
o PAHO, through the week 20/2009, 92,773 H1N1 cases
ere conﬁrmed in Latin America as well as in Caribbean
slands and a total of 2,494 deaths had been reported. Brazil
ccounted for the highest number of deaths and an elevated
ortality rate when compared to countries like Chile. Initial
ontainment measures, such as screening symptomatic peo-
le in airports and aircrafts and isolating patients who had
ecently traveled and presented ﬂu-like symptoms, proved
neffective. Different strategies developed in each coun-
ry showed that the early identiﬁcation and treatment of
igh risk patients were responsible for reducing mortality.
lthough some demographic differences and distinctive clin-
cal outcomes were noticed in different countries, various
eports demonstrated that patients with underlying condi-
ions such as asthma, diabetes, cardiac and lung diseases as
ell as pregnant women were more susceptible to complica-
ions. General experience made the beneﬁt of early use of
ntiviral drugs clear. Based on what had been learnt dur-
ng the pandemic and in line with WHO directives, Latin
merica countries are working on a vaccination program
argeting the most vulnerable populations. These countries
ad to deal with a high number of cases earlier than other
egions and before the impact on health care systems could
e observed. Cooperation between countries requires clear
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and quick exchange of information in order to control any
disease that presents the risk of spreading internationally.
doi:10.1016/j.ijid.2010.02.1496
07.004
Prospects on Inﬂuenza Vaccines
G. Baracco
University of Miami, Miami, FL, USA
The inﬂuenza pandemic of 2009 has brought renewed
interest in the development of new technologies for the
production of inﬂuenza vaccine. This presentation will
discuss the traditional production methods and available
clinical data of monovalent H1N1 inﬂuenza vaccine. New
advances in the ﬁeld of inﬂuenza vaccine manufacture
include increasing the speed of production and delivery
and expanding the breadth of immunologic coverage in the
search for a ‘‘universal target’’. We will discuss different
strategies being developed to achieve those goals, includ-
ing the use of adjuvants, utilization of reverse genetics, and
DNA vaccines. Lastly, we will discuss barriers to successful
immunization coverage and strategies to overcome them.
doi:10.1016/j.ijid.2010.02.1497
Rabies, bites and envenomations (Invited Presenta-
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Rabies, the Emerging Challenge
D. Warrell
University of Oxford, John Radcliffe Hospital, Oxford,
United Kingdom
Classic rabies (genotype 1) and 6 other rabies-related
lyssaviruses have proved capable of infecting humans. Anti-
bodies to unspeciﬁed lyssaviruses are being discovered in
bats in Europe, Asia and Africa. A case of Duvenhage (geno-
type 4) infection acquired from a bat in Kenya illustrated the
hidden menace, unlikely to be revealed except by chance
exposure of ‘‘sentinel humans’’ in whom a precise diagnosis
is possible.
Wild mammal vectors/reservoirs: New wild mammal vec-
tors and reservoirs are being identiﬁed, such as ferret
badgers (Melogale moschata) in SE China. The importance
of bats is increasingly recognised. Bites by rodents and mon-
keys are generally considered to carry a negligible risk of
rabies but in Brazil, pet marmosets (Callithrix jacchus) have
transmitted rabies.
Rabies control in domestic dogs: This is the most econom-
ical way of preventing human rabies. Potent and inexpensive
tissue culture vaccines (TCVs) are available. In India, a sin-
gle injection may protect stray dogs throughout their short
lives. Oral vaccination is being extended from wild mammals
to feral dogs.Tissue culture vaccines for human use: Phasing out ner-
vous tissue vaccines has encouraged manufacture of TCVs
in India, China and Brazil but quality regulation is difﬁcult.
Vaccine shortages in USA forced a shortening of the con-
a
s
dts e9
entional 5-dose Essen im regimen by deleting the day 28
ose.
Economical multi-site intradermal vaccination: eco-
omical and rapidly-immunogenic multisite intradermal
egimens such as a new 4-site id regimen can be used. Less
han 2 vials of vaccine and only 3 clinic visits are required.
Pre-exposure prophylaxis in travellers: In USA, the vac-
ine shortage prevented pre-exposure prophylaxis and, in
hese circumstance, id use may be condoned in the future.
Cure of human rabies encephalomyelitis: recovery of an
n-immunised American girl infected by a bat was attributed
o the ‘‘Milwaukee regime’’, but this approach has failed in
t least 17 subsequent cases.
oi:10.1016/j.ijid.2010.02.1498
8.002
nvenomation by Latin American arthropods
. Malaque
Vital Brazil Hospital, Sao Paulo, Brazil
In Latin America, the most dangerous venomous arthro-
ods are scorpions, spiders, bees and caterpillars. Scorpion
tings are especially common in urban areas of Mexico, Ama-
onia and Brazil. Although intense local pain is often the
nly symptom, scorpion stings can cause death from heart
ailure/acute pulmonary edema, especially in children. In
ases of systemic involvement, antivenom and symptomatic
reatment must be administered quickly. Loxosceles spider
ite can cause dermonecrosis or, more rarely, intravascular
emolysis and renal failure. Accidents can occur when a spi-
er is compressed against the body of a person, especially
uring dressing or sleeping. The timing of administration
nd the effectiveness of speciﬁc antivenom in neutralizing
ocal effects are controversial. Accidents with Phoneutria
the ‘‘armed’’ or ‘‘banana’’ spider) are most common in
outhern and southeastern Brazil. Phoneutria are found near
wellings, under logs, in crevices, in woodpiles and among
ananas. Most victims suffer only local pain. Autonomic
ervous system involvement (requiring administration of
peciﬁc antivenom) is most common in children. Latrodec-
us bite can cause local, regional, remote or generalized
ain, occasionally causing muscle cramps/spasms. Speciﬁc
ntivenom is reserved for severe cases. Mass bee attacks
ccur in warmer Central and South American regions,
otentially causing rhabdomyolysis, intravascular hemoly-
is, renal failure, respiratory distress, hepatic dysfunction
r myocardial damage. Lonomia caterpillar accidents can
roduce hemorrhagic disorders (effectively reversed with
onomia-speciﬁc antivenom), acute kidney injury, chronic
enal failure or death. Whole blood/fresh frozen plasma
ransfusion has been associated with worsening and slower
ecovery of the hemorrhagic syndrome. Most Lonomia acci-
ents occur in Venezuela and southern Brazil. Since Lonomia
ften cluster on fruit trees, accidents are most common
ear rural residences. Ecotourism has increased Lonomia
ccident rates in parks/reserves. Although most arthropod
ccidents have a benign course, travelers to endemic areas
hould be aware of the risks associated with envenomation.
oi:10.1016/j.ijid.2010.02.1499
